NIVF
NewGenIvf Group Limited
NASDAQ · Healthcare · Medical - Healthcare Plans · TH
$1.14
−3.39%Year over year
Reported trailing growth
- Revenue
- +258.9%
- EBITDA
- +1460.6%
- EBIT
- —
- EPS
- -74.1%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +1148.3%
- EBITDA
- -39.9%
- EPS
- +1869.0%
Three-year CAGR
- Revenue
- -7.4%
- EBITDA
- +146.3%
- EBIT
- —
- Net income
- +178.2%
- EPS
- -35.5%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Dec 1, 2025